Korify Capital has launched its first venture fund, Korify Capital Fund ONE, which is targeting USD100 million for breakthrough biotech investments with a focus on longevity and mental health.
Korify’s focus is to invest in companies that give people the opportunity to live longer, healthier, and happier lives by both preventing and treating age-related diseases and mental illnesses. The new fund is being launched at a time when the biotech sector is transforming rapidly through evolving artificial intelligence and machine learning, leading to diminished costs and a speeding up of vital development processes.
